Fibrosis

Liver infected with hepatitis. Illustration: depositphotos.com

When the virus leaves a mark: Epigenetic “stamp” after hepatitis C cure may explain ongoing risk of liver cancer

Research led by Prof. Meital Gal-Tanaami of Bar-Ilan University and supported by the Israel Science Foundation is examining how a virus that remains in the cytoplasm manages to change genetic control in the nucleus, and is attempting to map points of intervention to reduce cancer risk as well.
Heart disease and cancer and drug treatments – interactions

Between the heart and cancer: Technion researchers reveal surprising interrelationships between heart disease and cancerous tumors

Researchers at the Ruth and Baruch Rappaport Faculty of Medicine at the Technion present complex interrelationships between heart disease and cancer, in the hope that the findings will lead to improved treatment of both diseases.